Biogen Idec Inc. (BIIB) was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $299.1 to $328.27 in the past one-month time frame.
Over the last 30 days, the company did not witness any estimate revision but the Zacks Consensus Estimate moved higher. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Biogen currently sports a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.
Other well-performing biomedical stocks include Affymetrix Inc. (AFFX), ANI Pharmaceuticals, Inc. (ANIP) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment